Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT)
出版年份 2021 全文链接
标题
Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT)
作者
关键词
-
出版物
Trials
Volume 22, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-10-11
DOI
10.1186/s13063-021-05651-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative
- (2018) Tamas Constantin et al. ANNALS OF THE RHEUMATIC DISEASES
- MR-PheWAS: exploring the causal effect of SUA level on multiple disease outcomes by using genetic instruments in UK Biobank
- (2018) Xue Li et al. ANNALS OF THE RHEUMATIC DISEASES
- Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis
- (2018) Vanessa Cecchin et al. JOURNAL OF RHEUMATOLOGY
- Outcomes of non-infectious Paediatric uveitis in the era of biologic therapy
- (2018) Megan Cann et al. Pediatric Rheumatology
- JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
- (2017) Daniella M. Schwartz et al. NATURE REVIEWS DRUG DISCOVERY
- Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis
- (2017) Athimalaipet V. Ramanan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis
- (2017) Peter C. Taylor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment
- (2017) Roy Fleischmann et al. Arthritis & Rheumatology
- Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study
- (2016) Maxime Dougados et al. ANNALS OF THE RHEUMATIC DISEASES
- Baricitinib in Patients with Refractory Rheumatoid Arthritis
- (2016) Mark C. Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Juvenile idiopathic arthritis-associated uveitis
- (2016) Sarah L. N. Clarke et al. Pediatric Rheumatology
- Formulations for children: problems and solutions
- (2015) Hannah K. Batchelor et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Elicitation of Expert Prior Opinion: Application to the MYPAN Trial in Childhood Polyarteritis Nodosa
- (2015) Lisa V. Hampson et al. PLoS One
- Cytokines and Biologics in non-infectious autoimmune uveitis: Bench to Bedside
- (2014) Rupesh Agrawal et al. INDIAN JOURNAL OF OPHTHALMOLOGY
- Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis
- (2011) A. Heiligenhaus et al. RHEUMATOLOGY INTERNATIONAL
- Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050
- (2010) J. S. Fridman et al. JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More